NASDAQ$MDRX
Veradigm Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Allscripts reported increased revenue and earnings per share in Q3 2021, driven by solid execution and continued focus on client success and shareholder value.
Allscripts announced its Q3 2021 financial results, reporting revenue of $369 million and GAAP diluted EPS of $0.12. The company also generated $57 million of cash flow from continuing operations and $35 million of free cash flow. Allscripts is increasing its 2021 outlook for Adjusted EBITDA and free cash flow.
- GAAP diluted EPS was $0.12, while non-GAAP diluted EPS was $0.27, a 145% increase year-over-year.
- The company generated $57 million in cash flow from continuing operations.
- Free cash flow was $35 million in the third quarter.
- Allscripts is increasing its 2021 outlook for Adjusted EBITDA and free cash flow.
Headline financials
Revenue & EPS history
Allscripts · Revenue · Quarterly
$369M
Revenue by segment
Allscripts · $369M total across 2 segments · Q3 2021
- Software delivery, support...$223M—60.3%
- Client services$147M—39.7%
Forward guidance
Allscripts is revising its expectations for Adjusted EBITDA and free cash flow for 2021 and affirming revenue expectations.
Tailwinds
- Adjusted EBITDA is expected to be between $275 million and $285 million, an increase from the prior outlook of between $265 million and $275 million.
- Free cash flow is expected to be between $145 million and $155 million, an increase from the prior outlook of between $115 million and $125 million.
- Revenue is expected to be $1.5 billion.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
-0.3%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-0.9%
Avg return
30 days after
38%
20 / 52 earnings
Positive
+21.1%
Q2 2020
Best reaction
-17.9%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2022 | -0.2% | -0.8% | -1.3% | |
| Q3 2022 | +9.9% | +18.4% | +33.7% | |
| Q2 2022 | +11.1% | +9.6% | +5.4% | |
| Q1 2022 | +3.0% | +1.2% | -7.9% | |
| Q4 2021 | -2.1% | -0.2% | +9.4% | |
| Q3 2021 | +7.6% | +7.3% | +19.2% | |
| Q2 2021 | +1.7% | -0.3% | -11.1% | |
| Q1 2021 | +1.4% | +2.6% | +2.8% | |
| Q4 2020 | -4.8% | -6.4% | -5.6% | |
| Q2 2020 | +21.1% | +18.3% | +21.0% | |
| Q1 2020 | -7.2% | -14.8% | -10.1% | |
| Q4 2019 | -3.2% | +1.3% | -11.0% | |
| Q3 2019 | -4.1% | -3.5% | -13.5% | |
| Q2 2019 | -5.1% | -11.4% | -9.4% | |
| Q1 2019 | -0.3% | +1.4% | +3.5% | |
| Q4 2018 | -8.7% | -9.4% | -17.1% | |
| Q3 2018 | -17.9% | -10.7% | -15.2% | |
| Q2 2018 | -3.5% | -1.1% | +5.0% | |
| Q1 2018 | -2.3% | +0.0% | -5.9% | |
| Q4 2017 | +0.5% | +2.3% | -11.5% | |
| Q3 2017 | -3.5% | -2.2% | +10.5% | |
| Q2 2017 | +13.5% | +5.9% | +13.3% | |
| Q1 2017 | -1.4% | -2.1% | -5.5% | |
| Q4 2016 | +1.1% | -1.8% | -3.3% | |
| Q3 2016 | -9.8% | -11.5% | -9.6% | |
| Q2 2016 | -2.5% | -4.3% | -9.7% | |
| Q1 2016 | +3.5% | — | — | |
| Q4 2015 | +0.5% | — | — | |
| Q3 2015 | +4.5% | — | — | |
| Q2 2015 | +0.8% | — | — | |
| Q1 2015 | -1.3% | — | — | |
| Q4 2014 | +2.9% | — | — | |
| Q3 2014 | -16.8% | — | — | |
| Q2 2014 | -2.6% | — | — | |
| Q1 2014 | +1.6% | — | — | |
| Q4 2013 | +1.6% | — | — | |
| Q3 2013 | +1.5% | — | — | |
| Q2 2013 | -3.4% | — | — | |
| Q1 2013 | -0.9% | — | — | |
| Q4 2012 | -1.1% | — | — | |
| Q3 2012 | +0.0% | — | — | |
| Q2 2012 | +19.4% | — | — | |
| Q1 2012 | -0.0% | — | — | |
| Q4 2011 | -1.9% | — | — | |
| Q3 2011 | -2.8% | — | — | |
| Q2 2011 | -2.6% | — | — | |
| Q3 2010 | -0.2% | — | — | |
| Q2 2010 | -2.5% | — | — | |
| Q4 2009 | -2.5% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q4 2010 | -3.4% | — | — | |
| Q1 2010 | -3.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro